- Marksans Pharma Limited announced today that UK MHRA has granted Market Authorisation to the Company’s wholly owned subsidiary Bell Sons & Co. (Druggists) Limited for Bells Healthcare All in One Oral Solution.
- Each 20 ml dose contains Paracetamol Ph. Eur. 500.0 mg, Guaifenesin Ph. Eur. 200.0 mg and Phenylephrine Hydrochloride Ph. Eur. 10.0 mg.
- Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs.
- Marksans will manufacture the products at its UK MHRA approved facility Bell Sons & Co. (Druggists) Limited in UK.
Marksans Pharma receives UK MHRA approval for All in One Oral Solution
Related Posts
Leave a Reply
Recent News
